Hikal Limited (HIKAL)
ISIN: INE475B01022 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
393.6
7.75(2.01%)

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Pricing Updates

TODAY'S HIGH

404.2

TODAY'S LOW

380.75

52 WEEK HIGH

595

52 WEEK LOW

212

Major Holders

% of Shares Held by
All Insider

68.99%

% of Shares Held by
Institutions

6.01%

% of Float Held by
Institutions

19.38%

Number of Institutions
Holding Shares

17

Company Overview

MARKET CAP

4853.12 Cr.

ETERPRISE VALUE

5494.01 Cr.

NO. OF SHARES

12.33 Cr.

BOOK VALUE

87.362

DIV. YIELD

0.4%

DEBT

776.26 Cr.

GROSS PROFIT

900.11 Cr.

CASH

50.67 Cr.

REVENUE

1954.42 Cr.

REVENUE/SHARE

158.775

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-9.90 Cr.7.30 Lakhs7.30 Lakhs7.30 Lakhs
Change To Liabilities19.35 Cr.29.25 Cr.37.25 Cr.-3 Cr.
Total cashflows from Investing Activities-284.37 Cr.-156.19 Cr.-163.79 Cr.-124.59 Cr.
Net Borrowings66.45 Cr.-33.26 Cr.-25.01 Cr.19.33 Cr.
Total Cash from Financing Activities-5.56 Cr.-96.86 Cr.-100.86 Cr.-55.40 Cr.
Other Liabilities15.85 Cr.20.40 Cr.-55.34 Cr.43.56 Cr.
Total Assets0000
Net Income160.51 Cr.133.14 Cr.84.43 Cr.103.07 Cr.
Change in Cash3.80 Cr.-24.04 Cr.20.26 Cr.5.59 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities293.73 Cr.229.01 Cr.284.93 Cr.185.58 Cr.
Depreciation95.67 Cr.84.50 Cr.81.58 Cr.92.05 Cr.
Other Cashflows from Investing Activities-1.43 Cr.1.33 Cr.-5.80 Cr.3.52 Cr.
Dividends Paid-27.13 Cr.-14.81 Cr.-19.72 Cr.-13.56 Cr.
Change to Inventory-63.42 Cr.39.76 Cr.50.59 Cr.-61.17 Cr.
Change to Account Receivables46.91 Cr.-147.32 Cr.13.98 Cr.-69.07 Cr.
Other Cashflows from Financing Activities-44.88 Cr.-48.78 Cr.-56.12 Cr.-61.17 Cr.
Change to Net Income18.86 Cr.68.52 Cr.71.54 Cr.79.32 Cr.
Capital Expenditures-273.31 Cr.-157.59 Cr.-158.03 Cr.-128.42 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax218.57 Cr.206.42 Cr.126.57 Cr.149.08 Cr.
Minority InterestNoneNoneNoneNone
Net Income244.89 Cr.237.64 Cr.190.82 Cr.210.34 Cr.
Selling General Administrative203.38 Cr.168.09 Cr.160.37 Cr.138.83 Cr.
Gross Profit946.33 Cr.772.81 Cr.685.53 Cr.694.04 Cr.
Ebit244.89 Cr.237.64 Cr.190.82 Cr.210.34 Cr.
Operating Income244.89 Cr.237.64 Cr.190.82 Cr.210.34 Cr.
Other Operating Expenses402.39 Cr.281.83 Cr.251.86 Cr.251.98 Cr.
Interest Expense-31.21 Cr.-31.94 Cr.-49.24 Cr.-54.86 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense58.06 Cr.73.28 Cr.42.14 Cr.46 Cr.
Total Revenue1942.72 Cr.1720.43 Cr.1507.26 Cr.1589.60 Cr.
Total Operating Expenses1697.83 Cr.1482.79 Cr.1316.43 Cr.1379.26 Cr.
Cost of Revenue996.39 Cr.947.62 Cr.821.73 Cr.895.56 Cr.
Total Other Income Expense Net-26.32 Cr.-31.21 Cr.-64.25 Cr.-61.25 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.160.51 Cr.133.14 Cr.84.43 Cr.103.07 Cr.
Net Income Applicable to Common Shares160.51 Cr.133.14 Cr.84.43 Cr.103.07 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets10.29 Cr.10.25 Cr.10.85 Cr.8.24 Cr.
Capital Surplus038.12 Cr.38.12 Cr.38.12 Cr.
Total Liabilities1145.14 Cr.979.81 Cr.951.48 Cr.929.28 Cr.
Stock Holder Equity1067.98 Cr.933.40 Cr.816.50 Cr.756.21 Cr.
Minority Interest0000
Other Liabilities128.88 Cr.53.65 Cr.29.97 Cr.54.75 Cr.
Total Assets2213.12 Cr.1913.22 Cr.1767.98 Cr.1685.49 Cr.
Common Stock24.66 Cr.24.66 Cr.24.66 Cr.24.66 Cr.
Retained Earnings0819.31 Cr.702.41 Cr.641.90 Cr.
Other Liabilities89.04 Cr.59.56 Cr.50.84 Cr.28.87 Cr.
Good Will0000
Treasury Stock1043.32 Cr.51.30 Cr.51.30 Cr.51.52 Cr.
Other Assets73.94 Cr.67.21 Cr.96.50 Cr.62.80 Cr.
Cash49.09 Cr.7.63 Cr.31.68 Cr.11.41 Cr.
Current Liabilities769.20 Cr.656.78 Cr.596.32 Cr.602.57 Cr.
Long Term Asset Charges0000
Short Long Term Debt387.76 Cr.95.05 Cr.83.77 Cr.61.19 Cr.
Other Stockholder Equity1043.32 Cr.51.30 Cr.51.30 Cr.51.52 Cr.
Property Plant Equipment1163.97 Cr.956.54 Cr.885.18 Cr.783.40 Cr.
Total Cur. Assets964.28 Cr.878.60 Cr.774.76 Cr.830.02 Cr.
Long Term Investments64 Lakhs61.20 Lakhs68 Lakhs1.02 Cr.
Net Tangible Assets1057.69 Cr.923.15 Cr.805.64 Cr.747.96 Cr.
Short Term Investments10.27 Cr.28.93 Cr.31.67 Cr.20.10 Cr.
Net Receivables455.51 Cr.486.37 Cr.343.64 Cr.354.80 Cr.
Long Term Debt286.68 Cr.262.88 Cr.303.39 Cr.297.83 Cr.
Inventory328.98 Cr.266.69 Cr.312.46 Cr.364.23 Cr.
Accounts Payable249.06 Cr.229.61 Cr.201.16 Cr.160 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account